Our resource hub to discover reports, policy papers and other forms of informative content
The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
This study examines the contribution of Canada’s research and development (R&D) pharmaceutical sector to the Canadian economy in 2022. It builds upon the annual reports produced since 2018.
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (736 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget
Informative content to keep you up to date on the most pressing issues facing our industry.
